{
 "generic_name": "Semaglutide Tablet",
 "slug": "semaglutide-tablet",
 "brand_names": [
  "Rybelsus"
 ],
 "fda_status": [
  "To Be Discontinued"
 ],
 "last_fda_update": "06/04/2026",
 "first_posted": "06/04/2026",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Novo Nordisk, Inc.",
   "package_ndc": "0169-4303-30",
   "presentation": "Rybelsus, Tablet, 3 mg (NDC 0169-4303-30)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets."
  },
  {
   "company": "Novo Nordisk, Inc.",
   "package_ndc": "0169-4307-30",
   "presentation": "Rybelsus, Tablet, 7 mg (NDC 0169-4307-30)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets."
  },
  {
   "company": "Novo Nordisk, Inc.",
   "package_ndc": "0169-4314-30",
   "presentation": "Rybelsus, Tablet, 14 mg (NDC 0169-4314-30)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets."
  }
 ],
 "changes": []
}